ALB
Albemarle Corporation
NYSE · USBasic MaterialsChemicals - Specialty
$118.20-2.14%
Price as of Jul 20, 2026
ALB growth
Albemarle Corporation growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +7.9%
- EBITDA
- +216.4%
- EBIT
- +165.0%
- EPS
- +69.4%
- Free cash flow
- +469.1%
- Operating cash flow
- -5.0%
Forward estimates
- Revenue
- +13.5%
- EBITDA
- +38.1%
- EPS
- +353.1%
Three-year CAGR
- Revenue
- -11.1%
- EBITDA
- -46.4%
- EBIT
- -66.5%
- Net income
- +56.7%
- EPS
- +48.7%
- Free cash flow
- +2.3%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.